IRIS
FRANCESCHI, MARIA CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.187
AS - Asia 675
EU - Europa 545
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
Totale 2.434
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.176
CN - Cina 412
IE - Irlanda 213
SE - Svezia 205
SG - Singapore 175
TR - Turchia 64
FI - Finlandia 34
DE - Germania 33
CI - Costa d'Avorio 20
GB - Regno Unito 15
IT - Italia 15
IN - India 12
CA - Canada 11
IR - Iran 7
RO - Romania 7
BE - Belgio 5
EU - Europa 5
IL - Israele 4
CZ - Repubblica Ceca 3
HU - Ungheria 3
UA - Ucraina 3
NL - Olanda 2
AU - Australia 1
BG - Bulgaria 1
EG - Egitto 1
LT - Lituania 1
LU - Lussemburgo 1
PK - Pakistan 1
PL - Polonia 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 2.434
Salva come PNG Salva come JPEG
Città #
Chandler 354
Dublin 213
Santa Clara 178
Singapore 146
Beijing 77
Dearborn 74
Nanjing 62
Shanghai 56
Izmir 54
Ashburn 51
Boardman 42
Princeton 42
Helsinki 34
Shenyang 32
Wilmington 26
Kunming 21
Abidjan 20
Hebei 20
Nanchang 20
Jiaxing 18
San Mateo 18
Changsha 13
Tianjin 12
Frankfurt am Main 10
Ann Arbor 9
Guangzhou 9
Kocaeli 9
Jinan 8
Munich 8
Hefei 7
Pune 7
Toronto 7
Augusta 6
Bremen 6
Fremont 6
Hangzhou 6
Seattle 6
Timisoara 6
Brussels 5
Dallas 5
Draper 5
Edinburgh 5
Grafing 5
Los Angeles 5
Norwalk 5
Andover 4
Leawood 4
London 4
New York 4
Parma 4
Taizhou 4
Wuhan 4
Budapest 3
Cambridge 3
Fuzhou 3
Ningbo 3
Ottawa 3
Phoenix 3
Shijiazhuang 3
Zanjan 3
Ardabil 2
Borås 2
Brno 2
Castelnuovo Rangone 2
Chengdu 2
Jiangnong 2
Lanzhou 2
Legnaro 2
Monmouth Junction 2
Mumbai 2
Taiyuan 2
Amsterdam 1
Bangalore 1
Barnsley 1
Belgrade 1
Bratislava 1
Brindisi 1
Brisbane 1
Böblingen 1
Cairo 1
Changchun 1
Chongqing 1
Focsani 1
Houston 1
Islamabad 1
Istanbul 1
Jacksonville 1
Las Vegas 1
Laurel 1
Leicester 1
Lisbon 1
Luxembourg 1
Old Bridge 1
Olomouc 1
Quzhou 1
Redmond 1
Rockville 1
Sabz 1
Shaoxing 1
Sofia 1
Totale 1.831
Salva come PNG Salva come JPEG
Nome #
P.01.14: Overweight and Obesity as Risk Factors for Gerd Outcome: A 10 Years Study on a Gerd Population of 365 Patients 77
Rabepmzole in the treatment of non-responders GERD patients: a prospective six-month study 76
10 Day bismuth-based quadruple therapy for HP eradication in comparison with other therapies in a population with high clarithromycin resistance in northeast Italy 73
P.02.9: Prevalence of Atrophic Gastritis in General Population: A Gastropanel®-Based Study, Compared with Olga Histological Classification 72
P.02.5: PPI Test for Diagnosis of Body Atrophic Gastritis: A Prospective Study 72
Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers 71
Role of Helicobacter pylori infection on NSAIDs-related upper gastrointestinal bleeding in the elderly 70
PA.28 SERUM PEPSINOGEN I AS NON INVASIVE MARKER OF GASTRIC ACID SECRETION 69
Comparison of three different therapeutic regimens for eradicating Helicobacter pylori 69
P.01.7: Efficacy of PPIS and H-2 Blockers Therapy on Acid Suppression Assessed by Gastrin-17 and Pepsinogen I Serum Levels Determination in Gerd Patients 68
OC.07.3 RECOVERY OF GASTRIC FUNCTION AFTER ACETIUM® ADMINISTRATION: A 2 YEAR PROSPECTIVE STUDY IN PATIENTS WITH CHRONIC, ATROPHIC, BODY GASTRITIS 67
P.02.8: Chronic Atrophic Gastritis is Related with an Increased Risk for Cardiovascular Diseases, Assessed by Homocysteine Serum Levels Determination 65
The clinical usefulness of serum pepsinogens, specific IgG anti-HP antibodies and gastrin for monitoring Helicobacter pylori treatment in older people 65
P.02.7: The Branded Proton Pump Inhibitors (PPIS) Increase Levels of Gastrin 17 (G-17) More than the Generic Ones in Dyspeptic Patients from an Italian Primary Care Population 64
P.02.2: Improvement of Symptoms in Patients Affected by Chronic Athrophic Gastritis: A 2 Years Prospective Study by using L-Cysteine (Acetium™) 63
PA.7 CLINICAL VARIABILITY IN THE PRESENTATION OF THE GASTROESOPHAGEAL REFLUX DISEASE BEFORE THE HP ERA (STUDY FROM 1975 TO 1995) 62
P.14.3 A NON-INVASIVE MONITORING OF THE FUNCTIONALITY OF GASTRIC MUCOSA (GASTROPANEL TEST) IN DYSPEPTIC PATIENTS: A PRELIMINARY STUDY 61
P.02.1: Individual Assessment of Gastric Acid Production by Means of a Non-Invasive Test: Relationship Between Maximal Acid Output and Serum Pepsinogen I Levels in Patients with Different Upper GI Diseases 61
OC.09.2: Appropriateness of PPI Administration in the Elderly: Evaluation of Acid Secretion and Atrophic Gastritis by Means of a Non-Invasive Test 61
PO.1 NERD AND ERD: THE SCENARIO IS CHANGING OVER THE TIME? A 30 YEARS FOLLOW UP STUDY 59
P.02.10: Bismuth-Containing Quadruple Therapy in Patients Infected by Helicobacter Pylori: A First Real Life Italian Experience 58
Prevalence of H. pylori resistance to antibiotics in North-East Italy: A multicentered study 58
P.04.3 SERUM PEPSINOGEN II LEVELS AND IGG ANTI HELICOBACTER PYLORI ANTIBODIES MAY REPRESENT A NON-INVASIVE METHOD FOR THE DIAGNOSIS AND MONITORING OF H PYLORI-RELATED GASTRITIS 57
P.02.19: Prevalence of H. Pylori Infection, Chronic Atrophic Gastritis and Reflux Disease in a Primary Care Population of North-East Italy with Serum Biomarker Panel (Gastropanel®) 57
P.02.15: The Role of Gastropanel in the Evaluation of the Appropriateness of Proton PUMP Inhibitor (PPI)-Therapy Prescription in a Primary Care Population 56
P.01.5: Serum Pepsinogen II as a Non-Invasive Marker for Diagnosis of Helicobacter Pylori Infection: A Prospective Study in a Cohort of Dyspeptic Patients 56
Serum Pepsinogen II as a non-invasive marker for diagnosis of Helicobacter pylori infection: a prospective study in a cohort of dyspeptic patients 56
P.04.9 DIAGNOSIS OF CHRONIC ATROPHIC GASTRITIS IN PRIMARY CARE SETTING BY MEANS OF GASTROPANEL®: A POPULATION STUDY ON 10,000 CONSECUTIVE PATIENTS 55
Different lansoprazole (LA) dosages in H. pylori (Hp) eradication therapy: A prospective multicenter randomized study comparing 30 MG B.I.D. vs. 15 MG B.I.D 54
The cure for Helicobacter pylori ((HP) infection with double or triple omeprazole-based therápies in the elderly: Effects on eradication rate, chronic gastritis and serum anti-HP antibodies and pepsinogens 54
P.07.2: Natural History of Symptomatic Uncomplicated Diverticular Disease: A 13-Year Prospective Study 53
LONG-TERM TREATMENT WITH MESALAMINE IN DIVERTICULAR DISEASE: A FIVE YEARS FOLLOW-UP STUDY 52
P.04.25 ROLE OF CYP2C19*17 AND CYP2C19*2 IN THE RESPONSE TO PROTON PUMP INHIBITORS TREATMENT IN PATIENTS WITH ESOPHAGITIS 52
P.16.3 IMPROVEMENT OF APPROPRIATENESS AND REDUCTION OF WAITING LISTS CONCERNING UPPER GI ENDOSCOPY OUTPATIENTS: A SINGLE-CENTRE PROSPECTIVE STUDY 50
Role of proton pump inhibitors in the prevention of upper GI bleeding in elderly acute and chronic NSAID users 50
Helicobacter pylori infection in asymptomatic elderly subjects living at home or in a nursing home: effects on gastric function and nutritional status 48
The effect of Helicobacter pylori infection on NSAID-related gastroduodenal damage in the elderly 48
P.17.5 UPPER GI BLEEDING: CLINICAL AND DEMOGRAPHIC FEATURES IN AN ENDOSCOPIC POPULATION STUDY OF NORTH-EAST ITALY 46
The efficacy of two doses of omeprazole for short- and long-term peptic ulcer treatment in the elderly 44
The effect of aging on oro-cecal transit time in normal subjects and patients with gallstone disease 43
La terapia delle malattie acido-correlate nell'anziano 39
P.09.9 DIAGNOSTIC ACCURACY OF AGE AND ALARM SYMPTOMS FOR UPPER GI MALIGNANCY IN PATIENTS WITH DYSPEPSIA IN AN ENDOSCOPIC UNIT 36
null 10
Totale 2.477
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.352
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.352
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020167 0 0 0 0 0 59 40 7 13 25 23 0
2020/202152 0 0 6 0 1 1 0 1 6 9 28 0
2021/2022183 0 0 0 9 20 5 0 16 6 17 16 94
2022/2023924 72 114 68 93 58 122 1 84 273 3 32 4
2023/2024249 14 26 4 9 23 56 4 26 12 12 32 31
2024/2025467 36 52 66 35 139 139 0 0 0 0 0 0
Totale 2.477